PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes mellitus |
| Sentences | 139 |
| PubMedID- 25815676 | Glucagon-like peptide-1 (glp-1) has been demonstrated to play an important role in type 2 diabetes mellitus, leading to cardiovascular diseases. |
| PubMedID- 22851545 | Background: endothelial damage and dysfunction are crucial mediators that link diabetes mellitus with atherosclerotic cardiovascular disease. |
| PubMedID- 23393213 | Second, the presence of microvascular diseases commonly present in patients with diabetes mellitus may contribute to progressive microvascular ischemia or microembolization that can be readily detectable by highly sensitive ctni assay. |
| PubMedID- 22952467 | A lot more research would be required to figure out how best to manage macrovascular disease in diabetes mellitus. |
| PubMedID- 23185202 | Cardiovascular disease is common in patients with diabetes mellitus and related clinical outcomes are worse compared with non-diabetics. |
| PubMedID- 25251664 | Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 21955281 | Background: type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. |
| PubMedID- 20959955 | Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 20210989 | In a more recent controlled study performed in our center [6], it was found that blood flow alterations (stenoses and/or occlusions) demonstrated in temporal arteries with doppler ultrasonography are neither specific nor sensitive for gca, since these findings were equally common among elderly individuals or patients with macrovascular disease associated with diabetes mellitus or stroke, due to the temporal artery atherosclerotic changes. |
| PubMedID- 22474525 | A therapeutic effect of myricetin in patients with cardiovascular diseases associated with diabetes mellitus has also been reported [4, 5]. |
| PubMedID- 24187621 | Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine. |
| PubMedID- 20639213 | diabetes mellitus increases the risk of developing cardiovascular diseases such as coronary artery disease and heart failure. |
| PubMedID- 25658588 | Abbreviations: bmi, body mass index; egfr, estimated glomerular filtration rate; proteinuria, proteinuria positive; dm, diabetes mellitus; cvd, history of cardiovascular disease; hyperuricemia, history of hyperuricemia including gout; alcohol, daily alcohol consumption; exercise, having regular exercise. |
| PubMedID- 20920303 | If hypertension and chronic renal disease co-exist, as is common in patients with diabetes mellitus, the risk of cardiovascular disease is heightened. |
| PubMedID- 22994452 | Regarding cardiovascular mortality, age, diabetes mellitus, history of cardiovascular disease, lvmi, lvef, cimt, and pwv were significant predictors (table2). |
| PubMedID- 26491340 | Background: hypertension is a highly prevalent risk factor for cardiovascular disease in patients with type 1 diabetes mellitus. |
| PubMedID- 21088641 | All had a history of diabetes mellitus with peripheral vascular disease. |
| PubMedID- 24432038 | Aggressive treatment of dyslipidemia will reduce the risk of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 24678413 | The exclusion criteria were subjects who had diabetes mellitus, history of cardiovascular disease and heart failure, presence of cerebrovascular disease, arrhythmias (atrial fibrillation), history of ophthalmic surgery, cataract which affects the corrected visual acuity, glaucoma, and vitreous and retinal diseases. |
| PubMedID- 24496227 | diabetes mellitus accelerates the development of atherosclerotic cardiovascular diseases. |
| PubMedID- 25214836 | Left ventricular hypertrophy (lvh) and albuminuria are both markers for cardiovascular diseases (cvds) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 26246459 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 23238663 | Dietary interventions that could reduce the risk of development of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm) would clearly be advantageous instead of expensive pharmacological treatments. |
| PubMedID- 26246173 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 26116592 | Plasma adiponectin levels inversely correlate to clinical parameters in type 2 diabetes mellitus patients with macrovascular diseases. |
| PubMedID- 24404539 | Clinically diagnosed diabetes mellitus with cardiovascular disease (dm+cvd) shall be the endpoint. |
| PubMedID- 23798924 | [1112] positive results in different clinical trials have strengthen the value and acceptance of hscrp, which is recommended as a predictive laboratory marker for cardiovascular disease risk in patients with diabetes mellitus. |
| PubMedID- 20485966 | The patient had controlled dyslipedemia, type ii diabetes mellitus, and hypertension; history of smoking, peripheral vascular disease, and myocardial infarction 20 years ago. |
| PubMedID- 22789419 | Patients with hypertension, diabetes mellitus, or the history of any cardiovascular disease were excluded from study. |
| PubMedID- 23396240 | This paper examines the usefulness of several noninvasive imaging techniques to study cardiovascular diseases in individuals with diabetes mellitus, with emphasis on nuclear cardiology, and proposes a diagnostic algorithm for detection of silent ischemia. |
| PubMedID- 21632491 | Sensitive cardiac troponin t assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the women's health study. |
| PubMedID- 23130159 | Patients with non-st-segment-elevation myocardial infarction were older, more likely to be women, and more likely to have hypertension, diabetes mellitus, and a history of past cardiovascular disease than were patients with st-elevation myocardial infarction. |
| PubMedID- 24918803 | Interventions targeted at modifiable risk factors, such as smoking cessation and management of hypertension and dyslipidemia, reduce the risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 26130877 | Winners in each category were as follows: best fellow poster, "diet pattern and cardiovascular disease among women with type 2 diabetes mellitus," by hyun joon shin, md; best resident poster, "oral squamous cell carcinoma: current concepts in imaging, staging, and fibular osteocutaneous free-flap reconstruction," by r. |
| PubMedID- 19754853 | Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks. |
| PubMedID- 23144974 | In univariate analysis, age, diabetes mellitus, previous history of cardiovascular disease, smoking, lipid-lowering therapy, serum albumin, ipth, and hs-crp concentrations were significantly associated with the presence of aoac at baseline. |
| PubMedID- 20446592 | Numerous studies have demonstrated that insulin resistance, impaired glucose tolerance, and diabetes mellitus closely correlate with cardiovascular disease. |
| PubMedID- 23938049 | Dyslipidemia, undesirable changes in vascular endothelial and smooth muscle cells, lipid peroxidation especially oxidized low-density lipoprotein particles, oxidative damage and increased inflammatory mediators including chemokines and cytokines, hyper-coagulation and platelet activation have been considered as the main metabolic abnormalities in diabetes mellitus leading to cardiovascular disease [54]. |